US Stock MarketDetailed Quotes

TMDX TransMedics

Watchlist

159.140
+14.580+10.09%

Close Sep 27 16:00 ET

159.140
0.0000.00%

Post 20:02 ET

5.31BMarket Cap3978.50P/E (TTM)

TransMedics Stock Forum

Brianjh

Sep 23 05:53

IT ALWAYS STARTS AS A SOFT LANDING IN THE US

However, only one soft landing has been achieved since the 1980s and this was when the job market was actually improving... A soft landing is indeed our base case but the tail risk (i.e hard landing) should be assigned a reasonable probability
$NVIDIA (NVDA.US)$ $Palantir (PLTR.US)$ $Taiwan Semiconductor (TSM.US)$ $Tesla (TSLA.US)$ $Netflix (NFLX.US)$ $Microsoft (MSFT.US)$ $Alphabet-C (GOOG.US)$ $Apple (AAPL.US)$ $TransMedics (TMDX.US)$ $Novo-Nordisk A/S (NVO.US)$ $Walmart (WMT.US)$ $Coinbase (COIN.US)$ $Roundhill Magnificent Seven ETF (MAGS.US)$ $Amazon (AMZN.US)$ $Meta Platforms (META.US)$ $Advanced Micro Devices (AMD.US)$ $Vanguard S&P 500 ETF (VOO.US)$ $SPDR S&P 500 ETF (SPY.US)$ $iShares Core S&P 500 ETF (IVV.US)$ $Invesco QQQ Trust (QQQ.US)$ $Invesco NASDAQ 100 ETF (QQQM.US)$

Tech outperforms after jumbo Fed rate cut: Are bullish signals coming?

Melon Musk

Sep 21 10:07

$TransMedics (TMDX.US)$ this is a great buy for me. long term investors should cop some of this for their portfolio

Brianjh

Sep 12 09:21

Yesterday CPI Data

The most important number of the day wa CPI number. Inflation in August declined to its lowest level since February 2021, according to a Labor Department report Wednesday that also showed a key measure higher than expected, setting the stage for an expected quarter percentage point rate cut from the Federal Reserve.
Indeed, while the headline CPI increased 0.2% for the month, in line with the Dow Jones consensus, the core CPI, which excludes volatile food and energy prices, inc...

CPI hits 3-year low: How will it sway the Fed rate decision?

ROM-STAR

May 27 08:03

Owning stocks isn't enough -- you must understand what these companies do. If you can't summarize their business in one sentence, you might not truly know them.
Here are the one-liners for each stock in my portfolio 🧐
1. $CrowdStrike (CRWD.US)$ | Crowdstrike
• Their Falcon platform uses artificial AI and cloud technology to detect and respond to cyber threats by offering endpoint security, threat intelligence, and cyberattack response services.
2. $Snowflake (SNOW.US)$ | Snowflake
• A cloud-...

Pongz

May 1 00:31

$TransMedics (TMDX.US)$ more than 13% increase duruing post-market is unbelievable.

Moomoo AI

Mar 11 09:53

TransMedics Group's trend of growing ROCE and increasing capital employed suggests profitable reinvestment opportunities, potentially leading to a multi-bagger performance. The stock's solid return to shareholders over the last three years indicates investor recognition of these changes.

The Return Trends At TransMedics Group (NASDAQ:TMDX) Look Promising

Rockyturki

Mar 10 22:19

$Advanced Micro Devices (AMD.US)$ was obvious to buy at $100 and many waited
$Celsius Holdings (CELH.US)$ at $48 (this year) was the easiest money and people waited.
$Palantir (PLTR.US)$ at $14 was extremely undervalued and many waited
$Meta Platforms (META.US)$ was obvious to buy at $200 and everyone waited
$CrowdStrike (CRWD.US)$ was a clear buy at $150 and people waited
$TransMedics (TMDX.US)$ at $38 with a market cap of $1 Billion was a steal and nobody wanted to buy it.
Focus on the essentials: align...

Kevin Travers

Feb 27 10:02

Columns Biotechnology Stocks Climbing on Earnings and Test Results: What to Watch

$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks.
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...

Moomoo AI

Jan 25 08:59

Insider selling over the past year, particularly in recent months, may indicate insiders believe shares are overpriced. Despite some insider buying, the long-term outlook lacks positivity. Insider ownership shows alignment with shareholders, but past sales warrant caution.

TransMedics Group Insiders Sell US$2.1m Of Stock, Possibly Signalling Caution

Moomoo AI

Dec 14, 2023 06:08

TransMedics Group's significant top-line growth is undermined by its negative EBIT, liabilities outstripping cash and near-term receivables by $75m, and increased cash burn over the past year, constituting substantial risk.

Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data